Form 4: Kiniksa Pharmaceuticals International Director Reports Stock
Insider Transaction (Form 4)
Barry D Quart, a Director of Kiniksa Pharmaceuticals International, plc, reported a transaction in 2,600 shares of common stock on August 19, 2026.
Summary
- Bona fide gift: disposed of 2,600 Class A Ordinary Share on August 19, 2026; holds 12,745 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Barry D Quart — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Bona fide gift | Class A Ordinary Share | 2,600 | — | — | 12,745 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Bona fide gift (2,600 shares) |
Keywords
insider transaction, Form 4, KNSA, Kiniksa Pharmaceuticals International, plc, neutral, Barry D Quart
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.